latest news releases from the newsroom
Options to Hydro Top Management
OSLO, Norway, July 6, 2005 (PRIMEZONE) -- As a continuation of the company's short- and long-term incentive systems, Hydro's Board has agreed to allocate options to around 30 persons in Hydro top management. The distribution will be as follows: 15,000 options for the President and CEO, 7000 - 10,000 for the remaining four members of Corporate Management, and 2500 - 3500 for the other top executives in this scheme.
O-Pen A/S Raises EUR 6 Million in an International Funding Round
STOCKHOLM, Sweden, July 6, 2005 (PRIMEZONE) -- Danish developer of advanced display technologies O-pen A/S has raised more than EUR 6 million in an international funding round that primarily includes Danish investors Vaekstfonden and Seed Capital Denmark and Swedish early-stage investor InnovationsKapital. Proceeds from the round will be used to further build the development and commercial teams, bring the technology to volume production and expand the company's growing base of industrial customers and business partners.
Galapagos Signs Research Collaboration Agreement
MECHELEN, Belgium, July 6, 2005 (PRIMEZONE) -- Galapagos announced today that it has entered into a research collaboration with Novartis Pharmaceuticals UK Limited. Under the agreement, Galapagos' genomics partnering division Galadeno will design a research program for Novartis employing its SilenceSelect(R) (gene knock-down) platform for functional assays in human primary cell assays. The SilenceSelect technology is based on Galadeno's collection of adenoviruses with human gene sequences that specifically knock down over 4,000 different human proteins by producing siRNA in a human cell.Under the terms of the agreement, Galadeno will provide technology, reagents and support to enable Novartis to validate drug targets by analyzing human protein function in human primary cells. Galadeno will receive payments related to the research services and its SilenceSelect technology.
Dobson Communications Corporation
Dobson Communications Successfully Completes and Closes Notes Exchange Offer
OKLAHOMA CITY, July 5, 2005 (PRIMEZONE) -- Dobson Communications Corporation (Nasdaq:DCEL) today announced that it successfully completed and closed the offer to exchange (the "Offer") up to $250 million principal amount of the 8 3/8% First Priority Senior Secured Notes due 2011, $250 million principal amount of the First Priority Senior Secured Floating Rate Notes due 2011 and $325 million principal amount of the 9 7/8% Second Priority Senior Secured Notes due 2012 that were issued by its subsidiary Dobson Cellular Systems, Inc. ("Dobson Cellular") on November 8, 2004 in a private placement pursuant to Rule 144A and Regulation S under the Securities Act of 1933 (the "Securities Act") for like principal amounts of 8 3/8% First Priority Senior Secured Notes due 2011, First Priority Senior Secured Floating Rate Notes due 2011 and 9 7/8% Second Priority Senior Secured Notes due 2012 that have been registered under the Securities Act. As of 5:00 p.m., New York City time, on Friday, July 1, 2005, Dobson Cellular had received tenders of approximately 99.6 percent of the 8 3/8% First Priority Senior Secured Notes due 2011, representing $249 million of the outstanding aggregate principal amount of $250 million of notes; 100 percent of the outstanding aggregate principal amount of $250 million of First Priority Senior Secured Floating Rate Notes due 2011; and 100 percent of the outstanding aggregate principal amount of $325 million of 9 7/8% Second Priority Senior Secured Notes due 2012. The Offer was made pursuant to a prospectus, dated May 31, 2005, that is part of a Registration Statement filed with the Securities and Exchange Commission, which was declared effective on May 31, 2005.
ATA Airlines, Inc.
ATA Reports June Scheduled Service Traffic
INDIANAPOLIS, July 5, 2005 (PRIMEZONE) -- ATA Airlines, Inc., the principal subsidiary of ATA Holdings Corp. (Pink Sheets:ATAHQ), today reported that June scheduled service traffic decreased 48.4 percent from 2004 to 622.6 million RPMs (revenue passenger miles). Capacity decreased 45.7 percent compared to 2004 to 810.5 million ASMs (available seat miles). ATA's June scheduled service passenger load factor decreased 4.1 points to 76.8 percent. There were 493,432 passengers enplaned in June, a decrease of 48.9 percent.
Biophan CEO Discusses Benefits of Definitive Agreements with Boston Scientific in Interview with BiomedDiscoveries.com
LOS ANGELES, July 5, 2005 (PRIMEZONE) -- BiomedDiscoveries.com, http://www.BiomedDiscoveries.com, the online source for exclusive investor information in the biotechnology sector, has posted an exclusive streaming audio interview with Michael Weiner, CEO of Biophan Technologies (OTCBB:BIPH), a developer of next-generation medical technology. In the interview, Mr. Weiner discusses Biophan's recent execution of definitive agreements covering an equity investment and technology license by leading medical device manufacturer Boston Scientific Corp. (NYSE: BSX).